Benjamin Atha

Digital PCR (dPCR) has become a practical tool in translational medicine as demands for precision and sensitivity continue to rise. Its ability to deliver reliable, absolute quantification has led to its growing use in gene expression analysis, rare variant detection, clinical diagnostics, and more. Strengths of dPCR Unlike traditional PCR, which relies on endpoint measurements, or qPCR, which estimates abundance through fluorescence and standard curves, dPCR follows a different strategy.

Choosing a sequencer has become more complex as new chemistries, instrument designs, and expanding applications narrow the differences between platforms. Even with this convergence, instrument choice remains a significant decision because it affects budgets, workflows, and the kinds of experiments a lab can support.

Recent advancements in digital PCR (dPCR) technology have significantly improved its sensitivity, precision, and affordability. These innovations have expanded the method’s capabilities and applications, with new platforms and assays now enabling faster and more accurate genetic analysis across oncology, pathogen surveillance, clinical diagnostics, and more. Recent advances in dPCR Since their introduction, dPCR platforms have undergone significant refinement.